Concerns over the presence of microplastics in human tissues are growing as studies increasingly report plastic particles in blood, lungs, and even the brain. However, experts caution that more rigorous scientific methods are needed to determine the true health impacts of these tiny pollutants.
A recent Nature article highlights the challenges researchers face in studying microplastics, including issues of sample contamination, small study sizes, and limitations in detection methods. While there is mounting evidence that microplastics are entering the human body, uncertainties remain about their biological effects and the validity of some findings.
A 2023 study published in the New England Journal of Medicine found a potential link between microplastics in arterial plaques and an increased risk of heart attacks and strokes. The study, which involved nearly 300 participants, suggested that those with higher concentrations of plastics in their arteries were more likely to suffer fatal cardiovascular events. The findings have sparked widespread discussion, being cited over 6,600 times on social media and in hundreds of news articles.
Other research has reported microplastics in various human tissues, including the placenta, breast milk, and even the brain. A study published last month examined 91 autopsied brains and estimated that plastics made up an average of 0.65% of brain tissue—equivalent to around 4.5 bottle caps’ worth of plastic.
Despite these alarming discoveries, many experts remain skeptical. Some studies report finding plastic particles as large as 3 mm in human blood, which contradicts established knowledge about how particles move through biological barriers. Scientists point out that particles larger than 10 micrometers (µm) are unlikely to cross from the gut or lungs into the bloodstream. Without clear explanations of how these plastics might travel within the body, the credibility of some findings remains in question.
One of the biggest hurdles in microplastic research is the risk of contamination. Laboratories themselves are hotspots for plastic pollution, and many tools used in scientific experiments—such as plastic pipettes and containers—can introduce microplastics into samples. This raises concerns about whether plastics detected in human tissues are truly internalized or if they were introduced during sample collection and analysis.
Additionally, different research teams use different methodologies, making it difficult to compare results. Some studies use specialized stainless-steel chambers to minimize contamination, while others rely on plastic-based equipment that could skew findings.
Scientists are now pushing for greater transparency and standardization in microplastic research. Experts suggest that an international working group, composed of chemists, epidemiologists, and toxicologists, should establish clear guidelines for studying microplastics in human health.
One proposed solution is a checklist similar to the PRISMA guidelines used in systematic reviews and meta-analyses. Such a checklist would require researchers to document their methods in detail, including steps taken to prevent contamination. Studies would also need to discuss the biological plausibility of their findings and disclose uncertainties in their results.
While environmental microplastic pollution is undeniable, its direct impact on human health remains uncertain. Some laboratory experiments have shown that nanoplastics can interact with mammalian cells in ways that resemble neurodegenerative diseases like Parkinson’s. However, real-world evidence linking microplastic exposure to disease is still lacking.
To ensure that future policies are based on solid science, researchers must prioritize rigorous methods, data sharing, and open collaboration. Otherwise, misinformation and flawed regulations could hinder efforts to protect both human health and the environment.
